Clinical Trial Update: Bosentan in Treatment of Pulmonary Arterial Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on bosentan for pulmonary arterial hypertension. The study involving Eisenmenger syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eisenmenger Syndrome
• Pulmonary Arterial Hypertension

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Competence Network for Congenital Heart Defects | Conditions: Eisenmenger Syndrome | Phase 4 | Status: COMPLETED